Melting away plaque— the “melting butter sign”.
New results from the YELLOW-III study.
Note that these results are discussed (in detail) in a separate post here: ↪ YELLOW-III: statin plus evolocumab thickened fibrous caps over 30% in 6 months.
In just 6 months timeframe, this study showed a major reduction in total plaque volume (PAV), driven primarily by reduction of the soft lipid core (the “butter”) inside plaques. The study also showed a major increase in fibrous cap thickness (FCT) in just 6 months, which is known to stabilize existing plaque.
#reverseHD #statinreverseHD #pcsk9reverseHD #plaqueHD #lipidcoreHD #fibrouscapHD #statinsHD #pcsk9HD #yellowiiiHD #meltingbuttersignHD #pavHD #fctHD


